COSOL LIMITED (COS)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
COS - COSOL LIMITED
FNArena Sector : Software & Services
Year End: June
GICS Industry Group : Software & Services
Debt/EBITDA: 1.3
Index:
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$0.84
30 Nov |
0.000 OPEN $0.84 |
0.000 HIGH $0.84 |
0 LOW $0.84 |
| TARGET | |||||
|
|||||
| Franking for last dividend paid out: 100% | |||||
| OTHER COMPANIES IN THE SAME SECTOR | |||
| 360 . ADA . AHI . ALC . AMX . AND . ATA . BMT . DOC . DTC . EVS . GTK . KYP . NET . NXL . QOR . RDY . SKO . UBN . VGL . XF1 . YOJ . Z2U . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
| Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
|---|---|---|---|---|
| EPS (cps) | xxx | 5.4 | 5.9 | xxx |
| DPS (cps) | xxx | 2.5 | 3.0 | xxx |
| EPS Growth | xxx | 35.4% | 8.7% | xxx |
| DPS Growth | xxx | 28.1% | 22.0% | xxx |
| PE Ratio | xxx | N/A | 14.2 | xxx |
| Dividend Yield | xxx | N/A | 3.6% | xxx |
| Div Pay Ratio(%) | xxx | 45.3% | 50.8% | xxx |
Dividend yield today if purchased 3 years ago: 3.24%
Last ex-div: 19/10 - ex-div 1.46c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
| Title | 2021 | 2022 | 2023 |
|---|---|---|---|
| EPS Basic | xxx | xxx | 5.4 |
| DPS All | xxx | xxx | 2.5 |
| Sales/Revenue | xxx | xxx | 75.1 M |
| Book Value Per Share | xxx | xxx | 28.9 |
| Net Operating Cash Flow | xxx | xxx | 4.7 M |
| Net Profit Margin | xxx | xxx | 10.63 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2021 | 2022 | 2023 |
|---|---|---|---|
| Return on Capital Employed | xxx | xxx | 20.71 % |
| Return on Invested Capital | xxx | xxx | 16.70 % |
| Return on Assets | xxx | xxx | 11.47 % |
| Return on Equity | xxx | xxx | 20.71 % |
| Return on Total Capital | xxx | xxx | 21.74 % |
| Free Cash Flow ex dividends | xxx | xxx | 1.6 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
| Title | 2021 | 2022 | 2023 |
|---|---|---|---|
| Short-Term Debt | xxx | xxx | 2 M |
| Long Term Debt | xxx | xxx | 13 M |
| Total Debt | xxx | xxx | 15 M |
| Goodwill - Gross | xxx | xxx | 43 M |
| Cash & Equivalents - Generic | xxx | xxx | 5 M |
| Price To Book Value | xxx | xxx | 2.65 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
| Title | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capex | xxx | xxx | 1.2 M |
| Capex % of Sales | xxx | xxx | 1.65 % |
| Cost of Goods Sold | xxx | xxx | 57 M |
| Selling, General & Admin. Exp & Other | xxx | xxx | 7 M |
| Research & Development | xxx | xxx | - |
| Investments - Total | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
COS STOCK CHART
FNArena News on COS
| 1 |
Rudi’s View: All-Weather Portfolio In 2023Nov 29 2023 - Rudi's View |
| 2 |
FNArena Corporate Results Monitor – 24-08-2023Aug 24 2023 - Australia |
Latest Software & Services News
| 1 |
Dropsuite Trajectory ImpressesOct 25 2023 - Small Caps |
| 2 |
NextDC Invests For Megatrend MegademandSep 06 2023 - Australia |
| 3 |
USA Market Too Small For Overachieving Life360Aug 17 2023 - Small Caps |
| 4 |
Research To Download: Pharma & Biotech, Pointerra, Rent.com.au, & MoreAug 09 2023 - FYI |
| 5 |
Numbers Are Adding Up For Life360May 23 2023 - Small Caps |
| 6 |
Prospects Brighten Further For NextDCApr 17 2023 - Australia |
| 7 |
Xero Sees The Value Of ProfitMar 14 2023 - Australia |
| 8 |
Xero In FocusFeb 28 2023 - Technicals |
| 9 |
Disciplined Hansen Technologies Remains UpbeatFeb 24 2023 - Small Caps |
| 10 |
Serko’s Future Tied-In With Booking.com JVJan 25 2023 - Small Caps |
